ロード中...
IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity
BACKGROUND: While adoptive transfer of T-cells has been a major medical breakthrough for patients with B cell malignancies, the development of safe and effective T-cell-based immunotherapy for central nervous system (CNS) tumors, such as glioblastoma (GBM), still needs to overcome multiple challenge...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246372/ https://ncbi.nlm.nih.gov/pubmed/34193567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002426 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|